204 related articles for article (PubMed ID: 32313131)
1. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
[TBL] [Abstract][Full Text] [Related]
2. The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Lin YC; Chen WJ; Huang CY; Shiue HS; Pu YS; Chen CH; Su CT
Toxicol Appl Pharmacol; 2017 Oct; 332():1-7. PubMed ID: 28733204
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
4. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of nucleotide-binding domain-like receptor protein 3 polymorphisms and environmental metals exposure on chronic kidney disease.
Hsueh YM; Chen WJ; Lin YC; Huang YL; Shiue HS; Lin YF; Hsieh RL; Chen HH
Sci Rep; 2022 Apr; 12(1):6307. PubMed ID: 35428826
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
7. Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Wang Y; Zhang Y; Sun Y; Wu J; Chang J; Xiong Z; Niu F; Gu S; Jin T
Mol Genet Genomic Med; 2019 Nov; 7(11):e966. PubMed ID: 31487124
[TBL] [Abstract][Full Text] [Related]
8. The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma.
Huang CY; Huang YL; Pu YS; Shiue HS; Chen WJ; Chen SS; Lin YC; Su CT; Hsueh YM
Chemosphere; 2016 Jul; 154():90-98. PubMed ID: 27038904
[TBL] [Abstract][Full Text] [Related]
9. Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure.
Huang CY; Su CT; Chung CJ; Pu YS; Chu JS; Yang HY; Wu CC; Hsueh YM
Toxicol Appl Pharmacol; 2012 Aug; 262(3):349-54. PubMed ID: 22659136
[TBL] [Abstract][Full Text] [Related]
10. Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population.
Zhang QB; Qing YF; He YL; Xie WG; Zhou JG
Clin Rheumatol; 2018 Jan; 37(1):235-244. PubMed ID: 29214547
[TBL] [Abstract][Full Text] [Related]
11. The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area.
Huang CY; Su CT; Chu JS; Huang SP; Pu YS; Yang HY; Chung CJ; Wu CC; Hsueh YM
Toxicol Appl Pharmacol; 2011 Dec; 257(3):349-55. PubMed ID: 21982800
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms in IL27 gene and renal cell carcinoma.
Pu Y; Chen P; Zhou B; Zhang P; Wang Y; Song Y; Zhang L
Biomarkers; 2015; 20(3):202-5. PubMed ID: 26161702
[TBL] [Abstract][Full Text] [Related]
14. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma.
Sakano S; Hinoda Y; Okayama N; Kawai Y; Korenaga Y; Eguchi S; Nagao K; Ohmi C; Naito K
Ann Oncol; 2007 Nov; 18(11):1817-27. PubMed ID: 17712032
[TBL] [Abstract][Full Text] [Related]
15. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
16. Inflammasome Genes' Polymorphisms in Egyptian Chronic Hepatitis C Patients: Influence on Vulnerability to Infection and Response to Treatment.
Estfanous SZK; Ali SA; Seif SM; Soror SHA; Abdelaziz DHA
Mediators Inflamm; 2019; 2019():3273645. PubMed ID: 30728751
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 p.Q705K and CARD8 p.C10X single nucleotide polymorphisms are not associated with susceptibility to rheumatoid arthritis: a meta-analysis.
Yang Z; Cao J; Yang Q; Zhang Y; Han L
Int J Rheum Dis; 2017 Oct; 20(10):1481-1491. PubMed ID: 28185410
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma.
Tian X; Zhang S; Zhang Q; Kang L; Ma C; Feng L; Li S; Li J; Yang L; Liu J; Qi Z; Shen Y
J Nutr Biochem; 2020 Nov; 85():108489. PubMed ID: 32827663
[TBL] [Abstract][Full Text] [Related]
19. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma.
Xing Q; Li R; Xu A; Qin Z; Tang J; Zhang L; Tang M; Han P; Wang W; Qin C; Du M; Zhang W
Cancer Med; 2019 Jun; 8(6):2886-2896. PubMed ID: 31038847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
